Connect with us

Technology

Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Published

on

SAN FRANCISCO, Nov. 19, 2024 /PRNewswire/ — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the fourth quarter and fiscal year 2024.

“We are pleased with the progress we made in fiscal 2024,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “As we enter fiscal 2025, we have strong momentum with Dolby Atmos and Dolby Vision, our imaging patent portfolio has gotten stronger with the GE Licensing acquisition, and we are excited about our opportunity with Dolby.io, which is well positioned to provide real time interactive experiences for sports and entertainment.”

Fourth Quarter Fiscal 2024 Financial Highlights

Total revenue was $305 million, compared to $291 million for the fourth quarter of fiscal 2023.GAAP net income was $59 million, or $0.61 per diluted share, compared to GAAP net income of $9 million, or $0.09 per diluted share, for the fourth quarter of fiscal 2023. On a non-GAAP basis, fourth quarter net income was $78 million, or $0.81 per diluted share, compared to $64 million, or $0.65 per diluted share, for the fourth quarter of fiscal 2023.Dolby repurchased approximately 251,000 shares of its common stock and ended the quarter with approximately $402 million of stock repurchase authorization available going forward.

Full Year Fiscal 2024 Financial Highlights

Total revenue was $1.27 billion, compared to $1.30 billion for the full year of fiscal 2023.GAAP net income was $262 million, or $2.69 per diluted share, compared to GAAP net income of $201 million, or $2.05 per diluted share, for the full year of fiscal 2023. On a non-GAAP basis, full year net income was $369 million, or $3.79 per diluted share, compared to $348 million, or $3.56 per diluted share, for the full year of fiscal 2023.Cash flows from operations were $327 million, compared to $367 million for the full year of fiscal 2023.

A complete listing of Dolby’s non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

We closed the acquisition of GE Licensing, which we expect to be accretive to margins and earnings on a non-GAAP basis in fiscal 2025, and which gives us a stronger position in imaging patents.We acquired THEO Technologies, expanding Dolby.io’s ability to offer customers the best solutions for real-time streaming experiences that drive fan engagement and interactivity.We added two new automotive partners in Q4; WEY, a Chinese car company that specializes in premium Crossovers and SUVs, and Smart, a JV between Mercedes and Geely. We now have over 20 automotive OEM partners supporting Dolby Atmos, up from 10 partners one year ago.Meta announced support for Dolby Atmos across its MetaQuest headset device lineup.Apple launched the iPhone 16, which supports Dolby Atmos and Dolby Vision, and records in Dolby Vision.Xiaomi announced new 4K QLED TVs that support Dolby Vision.Australia selected Dolby AC-4 as part of its new broadcast set-top-box specification.Polytron, an Indonesian TV OEM, launched a new TV that supports Dolby Atmos and Dolby Vision.Lenovo’s new Thinkpad X1 Carbon Gen 13 Aura Edition supports Dolby Vision, and its Thinkbook 16 Gen7+ and Thinkbook 16 Gen 7 supports Dolby Atmos.Alienware released 27 4K Dual Resolution Gaming Monitor that supports Dolby Atmos.

Upcoming Investor Event

Dolby is hosting an event at CES for the financial community where we will demonstrate a wide array of our technologies. The event will be held at 7:00 a.m. PT on Wednesday, January 8, 2025. Please send an email to IR@dolby.com for more information.

Dividend

Today, Dolby announced a cash dividend of $0.33 per share of Class A and Class B common stock, payable on December 10, 2024, to stockholders of record as of the close of business on December 3, 2024.

Revolving Credit Facility

On November 14, 2024, Dolby entered into a Credit Agreement with Bank of America for a $250 million revolving credit facility. The facility includes $150 million of uncommitted incremental capacity, has a five-year term and can be terminated early without penalty. Dolby has not drawn on the facility. Further details regarding the Credit Agreement are set out in a Form 8-K filed by Dolby with the U.S. Securities and Exchange Commission on November 19, 2024.

Financial Outlook

Dolby’s financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby’s future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see “Forward-Looking Statements” in this press release for a description of certain risks that Dolby faces, and the section captioned “Risk Factors” in its Annual Report on Form 10-K for fiscal 2024, to be filed on or around the date hereof.

Dolby is providing the following estimates for its first quarter of fiscal 2025:

Total revenue is estimated to range from $330 million to $360 million.Licensing revenue is estimated to range from $305 million to $335 million.Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $190 million to $200 million on a non-GAAP basis.Effective tax rate is anticipated to be around 20.5% on a GAAP basis and around 18.5% on a non-GAAP basis.Diluted earnings per share is anticipated to range from $0.53 to $0.68 on a GAAP basis and from $0.96 to $1.11 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2025:

Total revenue is expected to range from $1.33 billion to $1.39 billion.Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.Operating expenses are anticipated to range from $908 million to $918 million on a GAAP basis and from $765 million to $775 million on a non-GAAP basis.Dolby expects operating margins to be roughly 20% on a GAAP basis and to be roughly 33% on a non-GAAP basis.Diluted earnings per share is anticipated to range from $2.43 to $2.58 on a GAAP basis and from $3.99 to $4.14 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss fourth quarter and full year fiscal 2024 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Tuesday, November 19, 2024. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-800-715-9871 (+1-646-307-1963 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Tuesday, November 19, 2024, until 8:59 p.m. PT (11:59 p.m. ET) on Tuesday, November 26, 2024 by dialing 1-800-770-2030 (+1-609-800-9909 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby’s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby’s operating results in a manner that focuses on what Dolby’s management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby’s management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. For the fourth quarter of fiscal 2023, we excluded from non-GAAP net income and diluted earnings per share a restructuring charge of about $30 million comprised of approximately $13 million for severance and related benefits and an impairment loss of approximately $17 million related primarily to internally developed software for projects we are no longer pursuing. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Impact from Tax Reform: The enactment of the U.S. Tax Cuts and Jobs Act (Tax Reform), and any related amendments or revisions, requires certain discrete and infrequent charges that are not representative of current operating results and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby’s management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby’s business, including as a means to evaluate period-to-period comparisons. Dolby’s management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby’s GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the first quarter of fiscal 2025 and full year fiscal 2025, Dolby’s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are “forward-looking statements” that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby’s receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby’s ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby’s ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby’s SEC filings and reports, including the risks identified under the section captioned “Risk Factors” in its Annual Report on Form 10-K filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. Dolby partners with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.

 

DOLBY LABORATORIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts; unaudited)

Fiscal Quarter Ended

Fiscal Year Ended

September 27,
2024

September 29,
2023

September 27,
2024

September 29,
2023

Revenue:

Licensing

$                282,705

$                265,203

$             1,181,794

$             1,197,930

Products and services

22,101

25,359

91,927

101,814

Total revenue

304,806

290,562

1,273,721

1,299,744

Cost of revenue:

Cost of licensing

18,764

14,556

67,204

64,890

Cost of products and services

15,232

20,996

73,292

87,676

Total cost of revenue

33,996

35,552

140,496

152,566

Gross profit

270,810

255,010

1,133,225

1,147,178

Operating expenses:

Research and development

68,636

70,426

263,663

271,523

Sales and marketing

87,901

90,870

334,460

354,364

General and administrative

69,209

66,612

270,392

258,477

Restructuring charges/(credits)

(1,290)

30,596

6,384

47,061

Total operating expenses

224,456

258,504

874,899

931,425

Operating income/(loss)

46,354

(3,494)

258,326

215,753

Other income/(expense):

Interest income/(expense), net

6,854

9,280

34,077

28,086

Other income, net

6,526

3,247

20,076

6,214

Total other income

13,380

12,527

54,153

34,300

Income before income taxes

59,734

9,033

312,479

250,053

(Provision for)/benefit from income taxes

(868)

875

(48,163)

(48,409)

Net income including noncontrolling interest

58,866

9,908

264,316

201,644

Less: net income attributable to noncontrolling interest

(296)

(722)

(2,491)

(988)

Net income attributable to Dolby Laboratories, Inc.

$                  58,570

$                    9,186

$                261,825

$                200,656

Net income per share:

Basic

$                      0.61

$                      0.10

$                      2.74

$                      2.10

Diluted

$                      0.61

$                      0.09

$                      2.69

$                      2.05

Weighted-average shares outstanding:

Basic

95,395

95,701

95,544

95,771

Diluted

96,593

97,678

97,325

97,733

 

DOLBY LABORATORIES, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands; unaudited)

September 27,
2024

September 29,
2023

ASSETS

Current assets:

Cash and cash equivalents

$                482,047

$                745,364

Restricted cash

95,705

72,602

Short-term investments

139,148

Accounts receivable, net

315,465

262,245

Contract assets, net

197,478

182,130

Inventories, net

33,728

35,623

Prepaid expenses and other current assets

69,994

50,692

Total current assets

1,194,417

1,487,804

Long-term investments

89,267

97,812

Property, plant, and equipment, net

479,109

481,581

Operating lease right-of-use assets

39,046

40,199

Goodwill and intangible assets, net

967,722

575,836

Deferred taxes

219,758

201,860

Other non-current assets

120,609

94,674

Total assets

$             3,109,928

$             2,979,766

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$                  17,380

$                  20,925

Accrued liabilities

347,529

351,399

Income taxes payable

9,045

4,769

Contract liabilities

31,644

31,505

Operating lease liabilities

12,238

13,628

Total current liabilities

417,836

422,226

Non-current contract liabilities

34,593

39,997

Non-current operating lease liabilities

34,754

37,020

Other non-current liabilities

135,852

108,339

Total liabilities

623,035

607,582

Stockholders’ equity:

Class A common stock

53

53

Class B common stock

41

41

Retained earnings

2,496,255

2,391,990

Accumulated other comprehensive loss

(19,187)

(36,984)

Total stockholders’ equity – Dolby Laboratories, Inc.

2,477,162

2,355,100

Noncontrolling interest

9,731

17,084

Total stockholders’ equity

2,486,893

2,372,184

Total liabilities and stockholders’ equity

$             3,109,928

$             2,979,766

 

DOLBY LABORATORIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)

Fiscal Year Ended

September 27,
2024

September 29,
2023

Operating activities:

Net income including noncontrolling interest

$                264,316

$                201,644

Adjustments to reconcile net income to net cash provided by operating activities:

  Depreciation and amortization

75,559

82,558

  Stock-based compensation

119,825

118,486

  Amortization of operating lease right-of-use assets

11,768

12,956

  Amortization of premium on investments

(2,919)

(860)

  Benefit from credit losses

(2,256)

(793)

  Deferred income taxes

(21,612)

(18,337)

  Impairment loss on internally developed software

16,225

  Other non-cash items affecting net income

(10,828)

(2,800)

  Changes in operating assets and liabilities:

Accounts receivable, net

(28,967)

47,779

Contract assets, net

(8,707)

347

Inventories

(2,654)

(13,226)

Operating lease right-of-use assets

(8,420)

(8,817)

Prepaid expenses and other assets

10,097

3,868

Accounts payable and accrued liabilities

(34,554)

(52,315)

Income taxes, net

(4,501)

(8,722)

Contract liabilities

(9,738)

(8,379)

Operating lease liabilities

(5,263)

(5,818)

Other non-current liabilities

(13,894)

3,285

Net cash provided by operating activities

327,252

367,081

Investing activities:

Purchases of marketable securities

(160,198)

(172,955)

Proceeds from sales of marketable securities

234,061

54,964

Proceeds from maturities of marketable securities

157,729

176,833

Purchases of property, plant, and equipment

(30,007)

(30,339)

Business combinations, net of cash and restricted cash acquired

(487,877)

25,703

Net cash provided by/(used in) investing activities

(286,292)

54,206

Financing activities:

Proceeds from issuance of common stock

40,203

47,781

Repurchase of common stock

(160,001)

(149,276)

Payment of cash dividend

(114,579)

(103,407)

Distributions to noncontrolling interest

(5,164)

(266)

Purchase of noncontrolling interest in business combinations

(9,920)

Equity issued in connection with business combination

722

Shares repurchased for tax withholdings on vesting of restricted stock

(39,075)

(31,144)

Payment of deferred consideration for prior business combinations

(500)

Net cash used in financing activities

(287,814)

(236,812)

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

6,640

5,120

Net increase/(decrease) in cash, cash equivalents, and restricted cash

(240,214)

189,595

Cash, cash equivalents, and restricted cash at beginning of period

817,966

628,371

Cash, cash equivalents, and restricted cash at end of period

$                577,752

$                817,966

 

Licensing Revenue by Market
(unaudited)

The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, except percentage amounts):

Fiscal Quarter Ended

Fiscal Year Ended

Market

September 27, 2024

September 29, 2023

September 27, 2024

September 29, 2023

Broadcast

$     95,779

34 %

$    102,448

39 %

$    409,105

35 %

$      451,719

38 %

Mobile

48,701

17 %

36,122

14 %

235,774

20 %

243,897

20 %

CE

42,024

15 %

41,682

16 %

165,817

14 %

170,197

14 %

PC

34,077

12 %

27,240

10 %

141,300

12 %

124,362

10 %

Other

62,124

22 %

57,711

21 %

229,798

19 %

207,755

18 %

Total licensing revenue

$    282,705

100 %

$    265,203

100 %

$ 1,181,794

100 %

$   1,197,930

100 %

 

GAAP to Non-GAAP Reconciliations

(unaudited)

The following tables present Dolby’s GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the fourth quarter and fiscal years ended September 27, 2024 and September 29, 2023:

Net income:

Fiscal Quarter Ended

Fiscal Year Ended

(in thousands)

September 27,
2024

September 29,
2023

September 27,
2024

September 29,
2023

GAAP net income attributable to Dolby Laboratories, Inc.

$             58,570

$            9,186

$            261,825

$        200,656

Stock-based compensation (1)

29,679

28,195

119,825

118,486

Amortization of acquisition-related intangibles (2)

6,296

3,306

15,552

10,056

Restructuring charges/(credits)

(1,290)

30,596

6,384

47,061

Impact of Tax Reform

(10,042)

(10,042)

Income tax adjustments

(4,777)

(7,339)

(24,528)

(28,249)

Non-GAAP net income attributable to Dolby Laboratories, Inc.

$             78,436

$          63,944

$            369,016

$        348,010

(1) Stock-based compensation included in above line items:

Cost of products and services

$                  362

$               388

$               1,501

$            1,697

Research and development

9,703

9,643

38,214

39,472

Sales and marketing

9,994

9,279

40,128

40,038

General and administrative

9,620

8,885

39,982

37,279

(2) Amortization of acquisition-related intangibles included in above line items:

Cost of licensing

$               2,789

$                 62

$               2,890

$               248

Cost of products and services

768

650

2,350

3,248

Research and development

253

Sales and marketing

867

721

2,824

3,137

General and administrative

1,872

1,873

7,488

3,170

Diluted earnings per share:

Fiscal Quarter Ended

Fiscal Year Ended

September 27,
2024

September 29,
2023

September 27,
2024

September 29,
2023

GAAP diluted earnings per share

$                 0.61

$              0.09

$                 2.69

$              2.05

Stock-based compensation

0.30

0.29

1.23

1.21

Amortization of acquisition-related intangibles

0.06

0.03

0.16

0.10

Restructuring charges/(credits)

(0.01)

0.31

0.07

0.48

Impact of Tax Reform

(0.10)

(0.11)

Income tax adjustments

(0.05)

(0.07)

(0.25)

(0.28)

Non-GAAP diluted earnings per share

$                 0.81

$              0.65

$                 3.79

$              3.56

Weighted-average shares outstanding – diluted (in thousands)

96,593

97,678

97,325

97,733

The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the first quarter of fiscal 2025 and full year fiscal 2025 included in this release:

Gross margin:

Q1 2025

Fiscal 2025

GAAP gross margin

87.0 %

87.0 %

Stock-based compensation

0.1 %

0.1 %

Amortization of acquisition-related intangibles

2.9 %

2.9 %

Non-GAAP gross margin

90.0 %

90.0 %

Operating expenses (in millions):

Q1 2025

Fiscal 2025

GAAP operating expenses (low – high end of range)

$230 – $240

$908 – $918

Stock-based compensation

(37)

(134)

Amortization of acquisition-related intangibles

(3)

(9)

Non-GAAP operating expenses (low – high end of range)

$190 – $200

$765 – $775

Operating margin:

Fiscal 2025

GAAP operating margin

20% +/-

Stock-based compensation

10 %

Amortization of acquisition-related intangibles

3 %

Non-GAAP operating margin

33% +/-

Effective tax rate:

Q1 2025

GAAP effective tax rate

20.5 %

Stock-based compensation (low – high end of range)

(2%) – 0%

Amortization of acquisition-related intangibles (low – high end of range)

(1%) – 0%

Non-GAAP effective tax rate

18.5 %

Diluted earnings per share:

Q1 2025

Fiscal 2025

Low

High

Low

High

GAAP diluted earnings per share

$                 0.53

$              0.68

$                 2.43

$              2.58

Stock-based compensation

0.39

0.39

1.39

1.39

Amortization of acquisition-related intangibles

0.12

0.12

0.45

0.45

Income tax adjustments

(0.08)

(0.08)

(0.28)

(0.28)

Non-GAAP diluted earnings per share

$                 0.96

$              1.11

$                 3.99

$              4.14

Weighted-average shares outstanding – diluted (in thousands)

97,400

97,400

97,500

97,500

                                                               

Investor Contact:
Peter Goldmacher
415-254-7415
peter.goldmacher@dolby.com

Media Contact:
media@dolby.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-fourth-quarter-and-fiscal-year-2024-financial-results-302310222.html

SOURCE Dolby Laboratories, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Arize AI Collaborates with Microsoft to Enable More Effective Enterprise Deployment of Generative AI

Published

on

By

Arize AI now offers an integrated development experience on Microsoft Azure AI Foundry portal, SDK, and Command Line Interface (CLI)

CHICAGO, Nov. 19, 2024 /PRNewswire/ — Arize AI, a leader in AI observability and LLM evaluation, debuted a deeper collaboration with Microsoft and a raft of new integrations at Microsoft Ignite today.

The updates come at a critical inflection point for enterprise adoption of generative AI. Despite the fact that most enterprises are planning production deployments of LLMs, over half still cite issues like data privacy and difficulty pinpointing issues (i.e. accuracy of responses) as barriers standing in the way of moving from prototype to successful real-world deployment.

Azure AI’s advanced AI and cloud capabilities and Arize’s deeply integrated platform are helping enterprise teams – including Fortune 500 airlines, financial services firms, retailers, and technology companies – overcome these barriers.

With Arize embedded directly in Azure AI Studio and available on Azure Marketplace, AI teams at enterprises can easily launch essential LLM evaluation and observability tools from Arize while keeping data within Azure.

In addition to this push-button integration, the Arize platform has several new integration points with Azure. These include:

Azure AI App Template Gallery: Azure developers now have access to prebuilt Arize templates to help monitor models and LLM applications, troubleshoot retrieval and tool execution issues, and improve the RAG pipeline – all in a gallery that is regularly tested and used by thousands of developers across the globe, with built-in security including keyless authentication to reduce the risk of leaked API keys.Azure Native Integrations: Announced in private preview, developers now have an integrated development experience in the Azure portal, SDK, and CLI for Arize AI with integrated identity management and and seamless billing.Azure AI model catalog: Azure AI model catalog offers several pay-as-you-go inference APIs through Models-as-a-Service (MaaS); Arize’s integration with Azure MaaS enables teams to objectively evaluate LLM systems and trace complex issues.

“Microsoft Azure AI platform is relied on by top enterprises to deploy cutting edge generative AI applications, and we’re pleased to offer fully integrated tracing and evaluation tools to ensure safe and effective production deployments,” says Jason Lopatecki, CEO and Co-Founder of Arize AI.

“We are pleased to collaborate with Arize AI as they expand their integration of Azure to drive AI innovation for their customers. Evaluation and tracing are essential tools for anyone building systems with generative AI and Arize – particularly with its open-source Phoenix library – has been a leader in this area,” says Amanda Silver, Corporate Vice President, Developer Division at Microsoft Corp.

About Arize AI
Arize AI is an AI observability and LLM evaluation platform that helps teams deliver and maintain more successful AI in production. Arize’s automated monitoring and observability platform allows teams to quickly detect issues when they emerge, troubleshoot why they happened, and improve overall performance across both traditional ML and generative use cases. Arize is headquartered in Berkeley, CA

Media Contact: David Burch, press@arize.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/arize-ai-collaborates-with-microsoft-to-enable-more-effective-enterprise-deployment-of-generative-ai-302310859.html

SOURCE Arize AI

Continue Reading

Technology

BioCatch partners with Australian banks on launch of fraud and scams intelligence-sharing network

Published

on

By

ANZ, CBA, NAB, Suncorp Bank, Westpac form inaugural core of BioCatch Trust™ partners

SYDNEY, Nov. 20, 2024 /PRNewswire/ — Australia and New Zealand Banking Group (ANZ), Commonwealth Bank of Australia (CBA), National Australia Bank (NAB), Suncorp Bank (Norfina Limited), and Westpac today announced they’d joined BioCatch Trust™ Australia, a pilot of the world’s first inter-bank, behavior- and device-based, fraud and scams intelligence-sharing network.

BioCatch Trust™ adds an additional layer of behavioural- and device-based protection for customers at the above-named banks against fraud and scams, by assessing in real time the potential risks associated with the accounts to which customers direct their domestic online payments within BioCatch Trust™ Australia. If the network identifies risks associated with a receiving account, BioCatch provides this intelligence to the sending bank in real time, allowing the sending institution to review the transaction before any money leaves the sender’s account.

“Fraud and scam payments are nearly always transferred to mule accounts through which the criminal funnels their profits before withdrawing them,” BioCatch CEO Gadi Mazor said. “When the sending and receiving banks involved in these transactions share intelligence to identify potential money mules, it should reduce the number of customers who fall victim to scams and make a substantial dent in the ability of criminals to move their illegally attained money. We know the criminals behind these attacks swap tactics, strategies, intelligence, and technology with other rival cybercriminals. We’re proud to now offer Australian banks an opportunity to join their own intelligence-sharing network to fight back.”

BioCatch Trust™ combines behavioral intelligence with digital session, payment, account, device, and non-monetary event intelligence to assess the potential risks of receiving accounts on the network before an eligible payment is processed. This helps financial institutions prevent those types of scams where the fraudster manipulates the victim outside of a digital banking session (many scams originate via an email, text message, or social media post). BioCatch Trust™ accomplishes this while utilising proven pseudonymisation technology to help protect the identities of those customers within the BioCatch Trust™ network.

The strength of the BioCatch Trust™ network improves with each new financial institution that joins. As more banks contribute account intelligence, the system grows smarter and more effective, offering deeper insights and broader coverage. This collective intelligence helps to protect against existing, unknown, and emerging threats, significantly enhancing fraud detection across the Australian banking ecosystem.

BioCatch Trust™ complements existing networks that share information after a scam has taken place, assisting the sending bank to make real-time risk assessments of receiving accounts before the sender transfers away any money.

Commentary from participating banks:

“Scams are a widespread issue and a scourge on our community,” ANZ Head of Customer Protection Shaq Johnson said. “At ANZ, and across the banking sector, we must continue to invest in prevention and detection measures to help keep our customers safe from cybercriminals. BioCatch Trust™ is another capability we can adopt to help us in the continued fight against scams and fraud. We’re pleased to be part of the pilot and look forward to seeing how we can leverage the risk indicators and insights this tool offers to complement our existing anti-scam capabilities.”

“There’s always more we can do to protect Australians from scammers, and joining BioCatch Trust™ builds on the anti-scam innovations that CBA has already implemented to better protect Australians,” CBA Head of Group Fraud James Roberts said. “BioCatch Trust™ is the first time banks have been able to share information in real time before a payment is made. In a world-first, this will help protect Australians from losing money to scammers. CBA welcomes the continued sharing of anti-scam intelligence – both with other banks and also across broader industry, including social media companies and telcos through the anti-scam intelligence loop.”

“Scams are the plague of our times,” NAB General Manager of Group Investigations Chris Sheehan said. “We must take action to make Australia a tougher place for criminals to be successful. This is a global first and a great example of how Australia is embracing innovation and strategic partnerships to stop criminals in their tracks. We look forward to seeing this technology in action to help us protect customers and detect scams at scale, in real time.”

“Suncorp Bank is proud to be part of this innovative collaboration, which highlights the investment being made to protect banking customers from scammers,” Suncorp Bank Executive Manager of Financial Crime Operations and Strategy Paul Gardner said. “All financial institutions have a critical role to play in the fight against scammers, and the work delivered as part of this project is another important step towards further protection for all Australians.”

“Stopping scams is one of our highest priorities,” Westpac Head of Fraud Prevention Ben Young said, “so we’re pleased to add an extra layer of protection for customers. Working closely with other banks and providers in the ecosystem is our best bet for making Australia a harder place for scammers to operate.”

About BioCatch:

BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust, and ease coexist. Today, 34 of the world’s largest 100 banks and 237 total financial institutions rely on BioCatch Connect™ to combat fraud, facilitate digital transformation, and grow customer relationships. BioCatch’s Client Innovation Board – an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank – collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 93 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges. For more information, please visit www.biocatch.com.

PR contacts:

Mac King
BioCatch senior communications manager
Mac.King@BioCatch.com

Amanda Schultz
ANZ media and public relations manager
Amanda.Schultz@anz.com

CBA Media
media@cba.com.au

Amelia Harris
NAB senior communications advisor
Amelia.Harris@nab.com.au

Emily Arnold
Suncorp Bank
Suncorp senior corporate affairs advisor
Emily.Arnold@suncorpbank.com.au

Brooke Davie
Westpac media
Brooke.Davie@westpac.com.au

Logo – https://mma.prnewswire.com/media/1843699/biocatch_logo_rgb_2x_Logo.jpg

View original content:https://www.prnewswire.com/apac/news-releases/biocatch-partners-with-australian-banks-on-launch-of-fraud-and-scams-intelligence-sharing-network-302310866.html

SOURCE BioCatch

Continue Reading

Technology

The9 Limited to Hold Annual General Meeting on December 27, 2024, and to Issue Class B Ordinary Shares to its Chief Executive Officer

Published

on

By

SHANGHAI, Nov. 19, 2024 /PRNewswire/ — The9 Limited (Nasdaq: NCTY) (the “Company”), an established Internet company, today announced that it has called an extraordinary general meeting (the “AGM”) of shareholders and has approved the issuance of Class B ordinary shares to its chairman of the Board of Directors and chief executive officer Mr. Jun Zhu.

AGM

The AGM will be held at the BNY Mellon Office, Room No. 4, 26/F Three Pacific Place, 1 Queen’s Road East, Hong Kong on December 27, 2024 at 2:00 p.m., Hong Kong time to consider and vote on the following proposals (the “Proposals”) as further detailed in the notice of the AGM (the “Notice”):

1. “THAT:

Mr. Davin Alexander Mackenzie, whose term of office shall expire on the date of this Annual General Meeting, be re-elected and appointed as a Class II Director of the Company, effective from the closing of this Annual General Meeting, to serve for a three (3) year term ending at the 2027 Annual General Meeting or until his successor is duly elected and qualified.”

“THAT:

Mr. Chau Kwok Keung, whose term of office shall expire on the date of this Annual General Meeting, be re-elected and appointed as a Class II Director of the Company, effective from the closing of this Annual General Meeting, to serve for a three (3) year term ending at the 2027 Annual General Meeting or until his successor is duly elected and qualified.”

“THAT:

Mr. Ka Keung Yeung, whose term of office shall expire on the date of this Annual General Meeting, be re-elected and appointed as a Class II Director of the Company, effective from the closing of this Annual General Meeting, to serve for a three (3) year term ending at the 2027 Annual General Meeting or until his successor is duly elected and qualified.”

“THAT:

Mr. George Lai (Lai Kwok Ho), whose term of office shall expire on the date of this Annual General Meeting, be re-elected and appointed as a Class III Director of the Company, effective from the closing of this Annual General Meeting, to serve for a three (3) year term ending at the 2027 Annual General Meeting or until his successor is duly elected and qualified.”

Directors’ biography is set forth on page 126 of the 2023 Annual Report on Form 20-F available at http://www.the9.com/.

2. “THAT the authorized share capital of the Company shall be increased and amended to US$500,000,000 divided into (i) 43,000,000,000 Class A ordinary shares of a par value of US$0.01 each (“Class A Ordinary Shares”), (ii) 6,000,000,000 Class B ordinary shares of a par value of US$0.01 each (“Class B Ordinary Shares”) and (iii) 1,000,000,000 shares of a par value of US$0.01 each of such class or classes as the Board may determine in accordance with the Amended M&AA (as defined below), in each case having rights, preferences, privileges and restrictions set forth in the Amended M&AA, through the following variation and amendment:

by the creation of an additional 45,000,000,000 shares of a par value of U$0.01 each, consisting of (i) 38,700,000,000 Class A Ordinary Shares, (ii) 5,400,000,000 Class B Ordinary Shares, and (iii) 900,000,000 shares of a par value of US$0.01 each of such class or classes as the Board may determine in accordance with the Amended M&AA.

3. “THAT the Company’s Third Amended and Restated Memorandum and Articles of Association (the “Current M&AA”) be amended and restated by their deletion in their entirety and by the substitution in their place of the Fourth Amended and Restated Memorandum and Articles of Association in the form as attached as Exhibit A to the Notice (the “Amended M&AA”). The material amendments of the Amended M&AA to the Current M&AA are set forth as the Exhibit B to the Notice.

The detailed Proposals and additional information regarding the AGM can be found in the Notice and the form of proxy for the AGM. The Notice and form of proxy for the AGM are available on the Company’s website at https://www.the9.com/newsroom, and will also be furnished to the Securities and Exchange Commission on Form 6-K on or about November 20, 2024. In addition, the Company’s proxy materials (including the final proxy statement) will be mailed to shareholders and ADS holders.

The Board of Directors of the Company recommends that the Company’s shareholders and ADS holders vote FOR the Proposals.

The Board of Directors of the Company has fixed the close of business on November 25, 2024 as the record date (the “Record Date”) for determining the shareholders entitled to receive the Notice or any adjournment or postponement thereof. Holders of record of ordinary shares of the Company at the close of business on the Record Date are entitled to notice of, to attend and vote at, the AGM or any adjournment or postponement thereof. Holders of the Company’s American depositary shares (“ADSs”) who wish to exercise their voting rights for the underlying ordinary shares must act through the depositary of the Company’s ADS program, The Bank of New York Mellon.

Issuance of Class B Ordinary Shares

The Board of Directors of the Company has approved the issuance of 50,000,000 Class B ordinary shares to its chairman of the Board of Directors and chief executive officer Mr. Jun Zhu, in light of the Company’s expected revival of its online gaming business and its business expansion strategies of investing into, and creating joint ventures with, various companies in the artificial intelligence and online gaming industries potentially through share-based payments, which may lead to a substantial increase in the total issued and outstanding ordinary shares of the Company. The Board of Directors approved this issuance of Class B ordinary shares to ensure continuous control over the Company by its current management and retain long standing professional expertise and resources of Mr. Zhu in the online gaming industry.

Safe Harbor Statement

This current report contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potentially,” “expected,” and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond The9’s control. The9 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (“SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about The9’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: The9’s goal and strategies; The9’s expansion plans; The9’s future business development, financial condition and results of operations; The9’s expectations regarding demand for, and market acceptance of, its products and services; The9’s expectations regarding keeping and strengthening its relationships with business partners it collaborates with; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in The9’s filings with the SEC. All information provided in this current report is as of the date hereof, and The9 does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About The9 Limited 

The9 Limited (The9) is an Internet company based in China listed on Nasdaq in 2004. The9 has aimed to become a diversified high-tech Internet company.

View original content:https://www.prnewswire.com/news-releases/the9-limited-to-hold-annual-general-meeting-on-december-27-2024-and-to-issue-class-b-ordinary-shares-to-its-chief-executive-officer-302310882.html

SOURCE The9 Limited

Continue Reading

Trending